POXEL SA (POXEL.PA) Fundamental Analysis & Valuation

EPA:POXEL • FR0012432516

Current stock price

0.261 EUR
+0 (+1.56%)
Last:

This POXEL.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. POXEL.PA Profitability Analysis

1.1 Basic Checks

  • In the past year POXEL has reported negative net income.
  • In the past year POXEL had a positive cash flow from operations.
  • POXEL had negative earnings in each of the past 5 years.
  • POXEL had a negative operating cash flow in each of the past 5 years.
POXEL.PA Yearly Net Income VS EBIT VS OCF VS FCFPOXEL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • POXEL's Return On Assets of -272.29% is on the low side compared to the rest of the industry. POXEL is outperformed by 93.67% of its industry peers.
Industry RankSector Rank
ROA -272.29%
ROE N/A
ROIC N/A
ROA(3y)-313.52%
ROA(5y)-206.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
POXEL.PA Yearly ROA, ROE, ROICPOXEL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600

1.3 Margins

  • With a Gross Margin value of 52.02%, POXEL perfoms like the industry average, outperforming 51.90% of the companies in the same industry.
  • POXEL's Gross Margin has declined in the last couple of years.
  • POXEL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.62%
GM growth 5YN/A
POXEL.PA Yearly Profit, Operating, Gross MarginsPOXEL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. POXEL.PA Health Analysis

2.1 Basic Checks

  • POXEL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for POXEL has been increased compared to 1 year ago.
  • Compared to 5 years ago, POXEL has more shares outstanding
  • Compared to 1 year ago, POXEL has an improved debt to assets ratio.
POXEL.PA Yearly Shares OutstandingPOXEL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
POXEL.PA Yearly Total Debt VS Total AssetsPOXEL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • POXEL has an Altman-Z score of -31.54. This is a bad value and indicates that POXEL is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -31.54, POXEL is not doing good in the industry: 86.08% of the companies in the same industry are doing better.
  • POXEL has a debt to FCF ratio of 74.74. This is a negative value and a sign of low solvency as POXEL would need 74.74 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 74.74, POXEL is in the better half of the industry, outperforming 79.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 74.74
Altman-Z -31.54
ROIC/WACCN/A
WACC11.12%
POXEL.PA Yearly LT Debt VS Equity VS FCFPOXEL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

  • A Current Ratio of 0.26 indicates that POXEL may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.26, POXEL is doing worse than 92.41% of the companies in the same industry.
  • POXEL has a Quick Ratio of 0.26. This is a bad value and indicates that POXEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • POXEL has a Quick ratio of 0.26. This is amonst the worse of the industry: POXEL underperforms 92.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.26
POXEL.PA Yearly Current Assets VS Current LiabilitesPOXEL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. POXEL.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.29% over the past year.
  • The Revenue has grown by 249.95% in the past year. This is a very strong growth!
  • POXEL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -24.22% yearly.
EPS 1Y (TTM)38.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.15%
Revenue 1Y (TTM)249.95%
Revenue growth 3Y-20.88%
Revenue growth 5Y-24.22%
Sales Q2Q%87.87%

3.2 Future

  • The Earnings Per Share is expected to decrease by -21.44% on average over the next years. This is quite bad
  • The Revenue is expected to decrease by -18.07% on average over the next years. This is quite bad
EPS Next Y-10.48%
EPS Next 2Y-21.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-79.58%
Revenue Next 2Y-18.07%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
POXEL.PA Yearly Revenue VS EstimatesPOXEL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
POXEL.PA Yearly EPS VS EstimatesPOXEL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. POXEL.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for POXEL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for POXEL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
POXEL.PA Price Earnings VS Forward Price EarningsPOXEL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • 93.67% of the companies in the same industry are more expensive than POXEL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.2
EV/EBITDA N/A
POXEL.PA Per share dataPOXEL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

  • A cheap valuation may be justified as POXEL's earnings are expected to decrease with -21.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.44%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. POXEL.PA Dividend Analysis

5.1 Amount

  • POXEL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

POXEL.PA Fundamentals: All Metrics, Ratios and Statistics

POXEL SA

EPA:POXEL (4/10/2026, 7:00:00 PM)

0.261

+0 (+1.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-16
Earnings (Next)N/A
Inst Owners4.99%
Inst Owner ChangeN/A
Ins Owners3.45%
Ins Owner ChangeN/A
Market Cap14.03M
Revenue(TTM)7.66M
Net Income(TTM)-13.62M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.83
P/FCF 17.2
P/OCF 17.2
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-1.74
Fwd EYN/A
FCF(TTM)0.02
FCFY5.82%
OCF(TTM)0.02
OCFY5.82%
SpS0.14
BVpS-1.14
TBVpS-1.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -272.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.02%
FCFM 10.66%
ROA(3y)-313.52%
ROA(5y)-206.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.62%
GM growth 5YN/A
F-Score5
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 74.74
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.26
Altman-Z -31.54
F-Score5
WACC11.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.15%
EPS Next Y-10.48%
EPS Next 2Y-21.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)249.95%
Revenue growth 3Y-20.88%
Revenue growth 5Y-24.22%
Sales Q2Q%87.87%
Revenue Next Year-79.58%
Revenue Next 2Y-18.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y80.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-223.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.93%
OCF growth 3YN/A
OCF growth 5YN/A

POXEL SA / POXEL.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of POXEL SA (POXEL.PA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to POXEL.PA.


What is the valuation status for POXEL stock?

ChartMill assigns a valuation rating of 2 / 10 to POXEL SA (POXEL.PA). This can be considered as Overvalued.


How profitable is POXEL SA (POXEL.PA) stock?

POXEL SA (POXEL.PA) has a profitability rating of 1 / 10.